FAPI-4
|
|
FAPI-4 Eigenschaften
- Siedepunkt:
- 1144.1±65.0 °C(Predicted)
- Dichte
- 1.46±0.1 g/cm3(Predicted)
- storage temp.
- Store at -20°C
- L?slichkeit
- DMSO: 100 mg/mL (114.56 mM)
- pka
- 1.83±0.10(Predicted)
- Aggregatzustand
- Solid
- Farbe
- White to off-white
Sicherheit
FAPI-4 Chemische Eigenschaften,Einsatz,Produktion Methoden
Verwenden
FAPI-4 is a substituted pyrrolidinyloxoethyl quinolinecarboxamides and one type of theranostic ligand for fibroblast activation protein (FAP). FAPI-4 is a FAP inhibitor (FAPI) and has been studied for its pharmaceutical properties in the diagnose or treatment of diseases driven by the overexpression of FAPs.FAPI-4 Upstream-Materialien And Downstream Produkte
Upstream-Materialien
Downstream Produkte
FAPI-4 Anbieter Lieferant Produzent Hersteller Vertrieb H?ndler.
Global( 36)Lieferanten
Firmenname | Telefon | Land | Produktkatalog | Edge Rate | |
---|---|---|---|---|---|
ATK CHEMICAL COMPANY LIMITED | +undefined-21-51877795 |
ivan@atkchemical.com | China | 32965 | 60 |
Accela ChemBio Inc. | +1-858-6993322 |
info@accelachem.com | United States | 18419 | 58 |
TargetMol Chemicals Inc. | +1-781-999-5354 +1-00000000000 |
marketing@targetmol.com | United States | 32161 | 58 |
TargetMol Chemicals Inc. | |
support@targetmol.com | United States | 38631 | 58 |
Xian confluore Biological Technology Co., Ltd. | +86-15680926068 +86-15680926068 |
1924344760@confluore.cn | China | 2996 | 58 |
Aladdin Scientific | +1-+1(833)-552-7181 |
sales@aladdinsci.com | United States | 52924 | 58 |
Changsha MOL Changes Biotechnology Co., Ltd. | +8619375158599 |
info@molchanges.com | China | 5223 | 58 |
Nanchang Tianzhen Biotechnology Co., Ltd | 13173652190 |
pomy@tanzhenbio.com | China | 1865 | 58 |
Hangzhou Baige Pharmaceutical Technology Co. , Ltd. | 0571-85350119 15888826472 |
15888826472@163.com | China | 2729 | 58 |
Hangzhou Beiputai Biopharmaceutical Co., Ltd | 0571-85350119 15888826472 |
bptsales@163.com | China | 3851 | 58 |
- FAPI-4
- 187366
- (S)-2,2',2''-(10-(2-(4-(3-((4-((2-(2-cyano-4,4-difluoropyrrolidin-1-yl)-2-oxoethyl)carbamoyl)quinolin-6-yl)oxy)propyl)piperazin-1-yl)-2-oxoethyl)-1,4,7,10-tetraazacyclododecane-1,4,7-triyl)triacetic acid
- FAPI04
- (S)-2,2’,2’’-[10-[2-[4-[3-[[4-[[2-(2-Cyano-4,4-difluoro-1-pyrrolidinyl)-2-oxoethyl]carbamoyl]-6-quinolyl]oxy]propyl]-1-piperazinyl]-2-oxoethyl]-1,4,7,10-tetraazacyclododecane-1,4,7-triyl]triacetic Acid
- FAPI
- G-1002
- FAPI-4 Chemical Structure
- (S)-2,2',2''-(10-(2-(4-(3-((4-((2-(2-cyano-4,4-difluoropyrrolidin-1-yl)-2-oxoethyl)carbamoyl)quinolin-6-yl)oxy)propyl)piperazin-1-yl)-2-oxoethyl)-1,4,7,10-tetraazacyclododecane-1,4,7-triyl)triacetic acid
- (S)-2,2’,2’’-[10-[2-[4-[3-[[4-[[2-(2-Cyano-4,4-difluoro-1-pyrrolidinyl)-2-oxoethyl]carbamoyl]-6-quinolyl]oxy]propyl]-1-piperazinyl]-2-oxoethyl]-1,4,7,10-tetraazacyclododecane-1,4,7-triyl]triacetic Acid
- 1,4,7,10-Tetraazacyclododecane-1,4,7-triacetic acid, 10-[2-[4-[3-[[4-[[[2-[(2S)-2-cyano-4,4-difluoro-1-pyrrolidinyl]-2-oxoethyl]amino]carbonyl]-6-quinolinyl]oxy]propyl]-1-piperazinyl]-2-oxoethyl]-
- 2374782-02-0
- C40H54F2N10O10